The Deep Pelvic Endometriosis Index (dPEI) is a preoperative MRI-based score initially validated to predict surgical outcomes in patients undergoing laparoscopic treatment for deep pelvic endometriosis (DPE). Its applicability in robotic-assisted laparoscopy (RAL) has not yet been established. This study aimed to evaluate whether the dPEI can predict surgical outcomes following RAL for DPE. From February 2019 to December 2024, a retrospective analysis from a prospective database including patients undergoing RAL for DPE at Tenon Hospital, Paris, was performed. Preoperative staging was based on MRI and the dPEI scoring system, which evaluates the involvement of different anatomical compartments by deep endometriosis. Patients were classified into three categories: mild endometriosis (dPEI ≤ 2), moderate endometriosis (dPEI 3-4), and severe endometriosis (dPEI ≥ 5). Surgical outcomes including operative time, hospital stay, postoperative complications using the Clavien-Dindo classification and voiding dysfunction were assessed. A hundred and seventy patients were included. Overall complication rate was 24.7%, including 7.7% Clavien-Dindo grade > II. De novo voiding dysfunction occurred in 10.6% of patients, lasting > 1 month in 4.1%. dPEI categories showed a positive correlation with longer operative time (Spearman's ρ = 0.40, p < 0.001) and increased hospital stay (Spearman's ρ = 0.43, p < 0.001) and were also significantly associated with higher rates of grade > II complications (OR = 13.1; 95% CI [1.54-111.3], p = 0.02) and high incidence of voiding dysfunction (OR = 5.9; 95% CI [1.48-23.5], p = 0.01). Involvement of lateral compartments was associated with high operative time, hospital stay, and de novo voiding dysfunction. Our results support the dPEI as a useful preoperative tool for predicting surgical outcomes after RAL for DPE. Its use can improve patient counseling, and shared decision-making, particularly in cases of severe disease (dPEI ≥ 5).
深盆腔子宫内膜异位症指数(dPEI)是一种术前基于mri的评分,最初用于预测接受腹腔镜治疗的深盆腔子宫内膜异位症(DPE)患者的手术结果。其在机器人辅助腹腔镜(RAL)中的适用性尚未确定。本研究旨在评估dPEI是否可以预测DPE RAL术后的手术结果。从2019年2月至2024年12月,对包括在巴黎Tenon医院接受RAL治疗DPE的患者在内的前瞻性数据库进行回顾性分析。术前分期基于MRI和dPEI评分系统,该评分系统评估深部子宫内膜异位症累及不同解剖腔室。将患者分为轻度子宫内膜异位症(dPEI≤2)、中度子宫内膜异位症(dPEI 3-4)和重度子宫内膜异位症(dPEI≥5)三类。评估手术结果,包括手术时间、住院时间、术后并发症(Clavien-Dindo分类)和排尿功能障碍。共纳入170名患者。总并发症发生率为24.7%,其中Clavien-Dindo分级> II级为7.7%。10.6%的患者出现新发排尿功能障碍,4.1%的患者持续1 ~ 10个月。dPEI类型与手术时间较长(Spearman's ρ = 0.40, p II并发症(OR = 13.1; 95% CI [1.54-111.3], p = 0.02)和排尿功能障碍高发(OR = 5.9; 95% CI [1.48-23.5], p = 0.01)呈正相关。外侧腔室受累与高手术时间、住院时间和新生排尿功能障碍有关。我们的结果支持dPEI作为预测DPE RAL术后手术结果的有用术前工具。它的使用可以改善患者咨询和共同决策,特别是在严重疾病(dPEI≥5)的情况下。
{"title":"Validation of the deep pelvis endometriosis index (dPEI) to evaluate surgical outcomes of robotic-assisted surgery for endometriosis.","authors":"Adèle Reilhac, Shiwa Mansournia, Yohann Dabi, Clément Ferrier, Marie Florin, Meryl Dahan, Cyril Touboul, Isabelle Thomassin-Naggara, Emile Daraï","doi":"10.1007/s11701-026-03141-x","DOIUrl":"https://doi.org/10.1007/s11701-026-03141-x","url":null,"abstract":"<p><p>The Deep Pelvic Endometriosis Index (dPEI) is a preoperative MRI-based score initially validated to predict surgical outcomes in patients undergoing laparoscopic treatment for deep pelvic endometriosis (DPE). Its applicability in robotic-assisted laparoscopy (RAL) has not yet been established. This study aimed to evaluate whether the dPEI can predict surgical outcomes following RAL for DPE. From February 2019 to December 2024, a retrospective analysis from a prospective database including patients undergoing RAL for DPE at Tenon Hospital, Paris, was performed. Preoperative staging was based on MRI and the dPEI scoring system, which evaluates the involvement of different anatomical compartments by deep endometriosis. Patients were classified into three categories: mild endometriosis (dPEI ≤ 2), moderate endometriosis (dPEI 3-4), and severe endometriosis (dPEI ≥ 5). Surgical outcomes including operative time, hospital stay, postoperative complications using the Clavien-Dindo classification and voiding dysfunction were assessed. A hundred and seventy patients were included. Overall complication rate was 24.7%, including 7.7% Clavien-Dindo grade > II. De novo voiding dysfunction occurred in 10.6% of patients, lasting > 1 month in 4.1%. dPEI categories showed a positive correlation with longer operative time (Spearman's ρ = 0.40, p < 0.001) and increased hospital stay (Spearman's ρ = 0.43, p < 0.001) and were also significantly associated with higher rates of grade > II complications (OR = 13.1; 95% CI [1.54-111.3], p = 0.02) and high incidence of voiding dysfunction (OR = 5.9; 95% CI [1.48-23.5], p = 0.01). Involvement of lateral compartments was associated with high operative time, hospital stay, and de novo voiding dysfunction. Our results support the dPEI as a useful preoperative tool for predicting surgical outcomes after RAL for DPE. Its use can improve patient counseling, and shared decision-making, particularly in cases of severe disease (dPEI ≥ 5).</p>","PeriodicalId":47616,"journal":{"name":"Journal of Robotic Surgery","volume":"20 1","pages":"188"},"PeriodicalIF":3.0,"publicationDate":"2026-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145999391","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-16DOI: 10.1007/s11701-025-02863-8
Danilo Coco, Silvana Leanza
<p><p>For over 3 decades, laparoscopic cholecystectomy (LC) has been established as the standard surgical treatment for gallstone disease. Robotic cholecystectomy (RC) has emerged as an innovative alternative designed to overcome technical limitations of LC, offering enhanced visualization, improved instrument articulation, and superior ergonomics. Despite increasing global adoption, robust comparative evidence regarding operative outcomes, complication rates, patient-centered metrics, and economic impact remains limited. This systematic review and meta-analysis synthesizes the most recent evidence through 2025 to provide a comprehensive comparison of the safety, efficacy, and cost-effectiveness of LC versus RC. A comprehensive systematic search was conducted in PubMed, Embase, and the Cochrane Library from inception through December 2024, supplemented by manual searches through January 2025. Randomized controlled trials, prospective cohort studies, and retrospective cohort studies comparing LC and RC in adults were included. Two independent reviewers extracted data on patient demographics, operative outcomes, complications, length of hospital stay, patient-reported outcomes, and cost metrics. Methodological quality was assessed using the Cochrane Risk of Bias 2.0 tool for randomized trials and the Newcastle-Ottawa Scale for observational studies. Meta-analyses were performed for key outcomes, including operative time, blood loss, complications, conversion rates, and hospital stay duration. Heterogeneity was addressed using random-effects models, and subgroup analysis was performed based on study design and geographic region. Population-level context was provided using national databases, including the U.S. National Inpatient Sample (NIS), ACS NSQIP, and Medicare claims. A potential limitation is the exclusion of non-English language studies. 38 studies including over 412,000 patients were analyzed. LC accounted for approximately 85-95% of all cholecystectomy procedures globally, while RC utilization increased from < 1 to 3-26% across regions by 2024. Pooled analysis showed longer operative times for RC in Western centers (75 vs. 60 min; p < 0.001), whereas some Asian institutions reported shorter times with RC (22 vs. 33 min; p = 0.0025). Pooled analysis indicated a higher rate of bile duct injury with RC (0.72% vs. 0.23%; relative risk 3.12, 95% CI 2.34-3.91; p < 0.001) although this finding should be interpreted with caution due to potential confounders, such as early learning curve effects and coding variability in administrative data. RC demonstrated a lower risk of serious complications (odds ratio 0.82, 95% CI 0.69-0.98), reduced conversion to open surgery (odds ratio 0.44, 95% CI 0.32-0.61), and decreased likelihood of hospitalization ≥ 24 h (odds ratio 0.76, 95% CI 0.71-0.81). Overall hospital stay was similar between approaches (1.4-2.7 days). RC incurred higher costs ($5000-6000 vs. $2000-3000 per case; European centers: €2088 vs. €172
{"title":"Comparative effectiveness, safety, and cost of laparoscopic versus robotic minimally invasive cholecystectomy: a systematic review and meta-analysis.","authors":"Danilo Coco, Silvana Leanza","doi":"10.1007/s11701-025-02863-8","DOIUrl":"https://doi.org/10.1007/s11701-025-02863-8","url":null,"abstract":"<p><p>For over 3 decades, laparoscopic cholecystectomy (LC) has been established as the standard surgical treatment for gallstone disease. Robotic cholecystectomy (RC) has emerged as an innovative alternative designed to overcome technical limitations of LC, offering enhanced visualization, improved instrument articulation, and superior ergonomics. Despite increasing global adoption, robust comparative evidence regarding operative outcomes, complication rates, patient-centered metrics, and economic impact remains limited. This systematic review and meta-analysis synthesizes the most recent evidence through 2025 to provide a comprehensive comparison of the safety, efficacy, and cost-effectiveness of LC versus RC. A comprehensive systematic search was conducted in PubMed, Embase, and the Cochrane Library from inception through December 2024, supplemented by manual searches through January 2025. Randomized controlled trials, prospective cohort studies, and retrospective cohort studies comparing LC and RC in adults were included. Two independent reviewers extracted data on patient demographics, operative outcomes, complications, length of hospital stay, patient-reported outcomes, and cost metrics. Methodological quality was assessed using the Cochrane Risk of Bias 2.0 tool for randomized trials and the Newcastle-Ottawa Scale for observational studies. Meta-analyses were performed for key outcomes, including operative time, blood loss, complications, conversion rates, and hospital stay duration. Heterogeneity was addressed using random-effects models, and subgroup analysis was performed based on study design and geographic region. Population-level context was provided using national databases, including the U.S. National Inpatient Sample (NIS), ACS NSQIP, and Medicare claims. A potential limitation is the exclusion of non-English language studies. 38 studies including over 412,000 patients were analyzed. LC accounted for approximately 85-95% of all cholecystectomy procedures globally, while RC utilization increased from < 1 to 3-26% across regions by 2024. Pooled analysis showed longer operative times for RC in Western centers (75 vs. 60 min; p < 0.001), whereas some Asian institutions reported shorter times with RC (22 vs. 33 min; p = 0.0025). Pooled analysis indicated a higher rate of bile duct injury with RC (0.72% vs. 0.23%; relative risk 3.12, 95% CI 2.34-3.91; p < 0.001) although this finding should be interpreted with caution due to potential confounders, such as early learning curve effects and coding variability in administrative data. RC demonstrated a lower risk of serious complications (odds ratio 0.82, 95% CI 0.69-0.98), reduced conversion to open surgery (odds ratio 0.44, 95% CI 0.32-0.61), and decreased likelihood of hospitalization ≥ 24 h (odds ratio 0.76, 95% CI 0.71-0.81). Overall hospital stay was similar between approaches (1.4-2.7 days). RC incurred higher costs ($5000-6000 vs. $2000-3000 per case; European centers: €2088 vs. €172","PeriodicalId":47616,"journal":{"name":"Journal of Robotic Surgery","volume":"20 1","pages":"177"},"PeriodicalIF":3.0,"publicationDate":"2026-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145991409","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Robot-assisted orthopedic surgery has garnered significant attention, yet comprehensive bibliometric and visualization analyses in this field remain scarce. This study aims to systematically map and visualize the global research landscape of robot-assisted orthopedic surgery. Employing bibliometric analysis methods and a suite of visualization tools-including CiteSpace, VOSviewer, and Scimago Graphica-this study systematically examined literature on orthopedic robotic surgery published in the Science Citation Index Expanded (SCIE) core collection from 2005 to 2024, analyzing global research trends across multiple dimensions. These dimensions encompass annual publication volume, collaborative networks among countries/regions and institutions, journal co-occurrence, keyword co-occurrence and clustering, research evolution pathways, and emerging keywords. A total of 820 articles on orthopedic robotics were included from 2005 to 2024. Analysis indicates exponential growth in global orthopedic robotic surgery research, with annual publications increasing from 5 in 2005 to 185 in 2024. The United States (338 articles), China (152 articles), and the United Kingdom (94 articles) emerged as core publishing nations. Institutional collaborations formed four major clusters: North America, Europe, Asia-Pacific, and industry-academia-research partnerships. Key influential journals in orthopedic robotic surgery include the Journal of Arthroplasty, Journal of Knee Surgery & Sports Traumatology & Arthroscopy, International Journal of Computer-Assisted Radiology and Surgery, and International Journal of Orthopaedic Knee Surgery. Research hotspots are highly concentrated in three key areas: prosthesis stability and long-term survival in robot-assisted total hip arthroplasty (THA); precise alignment and soft tissue balance in robot-assisted total knee arthroplasty (TKA); and accurate navigation and safe placement of pedicle screws in robot-assisted spinal surgery. Emerging keywords indicate recent research emphasis on "lumbar spine," "national joint registries," "patient matching," and "total hip." Orthopedic robotic surgery research is currently undergoing rapid development, with technology integration, precision, and personalization emerging as primary future directions. This study provides a reference framework for researchers to track field trajectories and optimize research planning, while also offering theoretical support for clinical practice and technological innovation.
{"title":"Global research hotspots and emerging trends in orthopedic robotic surgery: a comprehensive bibliometric analysis.","authors":"Zhengyi Yang, Xiaohu Chang, Guangyu Fu, Xiaoxiao Wu, Jifeng Fan, Changming Zhou","doi":"10.1007/s11701-025-02998-8","DOIUrl":"10.1007/s11701-025-02998-8","url":null,"abstract":"<p><p>Robot-assisted orthopedic surgery has garnered significant attention, yet comprehensive bibliometric and visualization analyses in this field remain scarce. This study aims to systematically map and visualize the global research landscape of robot-assisted orthopedic surgery. Employing bibliometric analysis methods and a suite of visualization tools-including CiteSpace, VOSviewer, and Scimago Graphica-this study systematically examined literature on orthopedic robotic surgery published in the Science Citation Index Expanded (SCIE) core collection from 2005 to 2024, analyzing global research trends across multiple dimensions. These dimensions encompass annual publication volume, collaborative networks among countries/regions and institutions, journal co-occurrence, keyword co-occurrence and clustering, research evolution pathways, and emerging keywords. A total of 820 articles on orthopedic robotics were included from 2005 to 2024. Analysis indicates exponential growth in global orthopedic robotic surgery research, with annual publications increasing from 5 in 2005 to 185 in 2024. The United States (338 articles), China (152 articles), and the United Kingdom (94 articles) emerged as core publishing nations. Institutional collaborations formed four major clusters: North America, Europe, Asia-Pacific, and industry-academia-research partnerships. Key influential journals in orthopedic robotic surgery include the Journal of Arthroplasty, Journal of Knee Surgery & Sports Traumatology & Arthroscopy, International Journal of Computer-Assisted Radiology and Surgery, and International Journal of Orthopaedic Knee Surgery. Research hotspots are highly concentrated in three key areas: prosthesis stability and long-term survival in robot-assisted total hip arthroplasty (THA); precise alignment and soft tissue balance in robot-assisted total knee arthroplasty (TKA); and accurate navigation and safe placement of pedicle screws in robot-assisted spinal surgery. Emerging keywords indicate recent research emphasis on \"lumbar spine,\" \"national joint registries,\" \"patient matching,\" and \"total hip.\" Orthopedic robotic surgery research is currently undergoing rapid development, with technology integration, precision, and personalization emerging as primary future directions. This study provides a reference framework for researchers to track field trajectories and optimize research planning, while also offering theoretical support for clinical practice and technological innovation.</p>","PeriodicalId":47616,"journal":{"name":"Journal of Robotic Surgery","volume":"20 1","pages":"179"},"PeriodicalIF":3.0,"publicationDate":"2026-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12808197/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145985767","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-16DOI: 10.1007/s11701-025-03134-2
Jesús Elías Ortíz-Gómez, Paloma Sarai Arellanes-Herrera, Alberto Iván González-Barajas, Diego Escarraman-Martinez, Ashuin Kammar-García, Manuel Alberto Guerrero-Gutiérrez
Robotic-assisted bariatric surgery has shown sustained growth in recent years. However, evidence on its performance in the context of medical tourism is limited. This study describes the implementation of a robotic bariatric surgery program in a highly specialized center, analyzing the evolution of operative times and the learning curve of the surgical team. Observational, retrospective, and descriptive study that included all patients undergoing robotic-assisted bariatric surgery between January 2023 and May 2025. Demographic, clinical, and surgical variables were recorded, including total surgery time, docking time, and console time. Comparisons between years were made using ANOVA and Tukey's test, considering p < 0.05 as statistically significant. Ninetyfour cases were analyzed with a mean age of 42.8 (SD: 11.3) years and body mass index of 41.8 (SD: 7.7) kg/m²; 84% were women. Sleeve gastrectomy was the most frequent procedure (56.4%). The average docking, surgery and console times were 7.6 (SD: 3.0), 111.6 (SD: 51.0) and 69.6 (SD: 49.3) minutes, respectively. A significant decrease in docking time was observed over the years (p < 0.001), with no significant differences in surgical or console times. The progressive implementation of bariatric robotic surgery in a context of medical tourism is feasible. During the initial years of experience, a significant reduction in docking time was observed, while console and total operative times did not show statistically significant changes, similar to other international centers.
{"title":"Robotic-assisted bariatric surgery in medical tourism: a retrospective descriptive study.","authors":"Jesús Elías Ortíz-Gómez, Paloma Sarai Arellanes-Herrera, Alberto Iván González-Barajas, Diego Escarraman-Martinez, Ashuin Kammar-García, Manuel Alberto Guerrero-Gutiérrez","doi":"10.1007/s11701-025-03134-2","DOIUrl":"https://doi.org/10.1007/s11701-025-03134-2","url":null,"abstract":"<p><p>Robotic-assisted bariatric surgery has shown sustained growth in recent years. However, evidence on its performance in the context of medical tourism is limited. This study describes the implementation of a robotic bariatric surgery program in a highly specialized center, analyzing the evolution of operative times and the learning curve of the surgical team. Observational, retrospective, and descriptive study that included all patients undergoing robotic-assisted bariatric surgery between January 2023 and May 2025. Demographic, clinical, and surgical variables were recorded, including total surgery time, docking time, and console time. Comparisons between years were made using ANOVA and Tukey's test, considering p < 0.05 as statistically significant. Ninetyfour cases were analyzed with a mean age of 42.8 (SD: 11.3) years and body mass index of 41.8 (SD: 7.7) kg/m²; 84% were women. Sleeve gastrectomy was the most frequent procedure (56.4%). The average docking, surgery and console times were 7.6 (SD: 3.0), 111.6 (SD: 51.0) and 69.6 (SD: 49.3) minutes, respectively. A significant decrease in docking time was observed over the years (p < 0.001), with no significant differences in surgical or console times. The progressive implementation of bariatric robotic surgery in a context of medical tourism is feasible. During the initial years of experience, a significant reduction in docking time was observed, while console and total operative times did not show statistically significant changes, similar to other international centers.</p>","PeriodicalId":47616,"journal":{"name":"Journal of Robotic Surgery","volume":"20 1","pages":"176"},"PeriodicalIF":3.0,"publicationDate":"2026-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145991358","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-16DOI: 10.1007/s11701-025-03087-6
Rui Yan, Jun Ma, Zewen Li, Yalong Zhang, Kangyu Wang, Hao Wang, Jiangwei Man, Li Yang
{"title":"Global trends and hotspots in robot-assisted kidney transplantation: A bibliometric and visualization analysis based on CiteSpace.","authors":"Rui Yan, Jun Ma, Zewen Li, Yalong Zhang, Kangyu Wang, Hao Wang, Jiangwei Man, Li Yang","doi":"10.1007/s11701-025-03087-6","DOIUrl":"https://doi.org/10.1007/s11701-025-03087-6","url":null,"abstract":"","PeriodicalId":47616,"journal":{"name":"Journal of Robotic Surgery","volume":"20 1","pages":"180"},"PeriodicalIF":3.0,"publicationDate":"2026-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145985714","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-14DOI: 10.1007/s11701-025-03020-x
Xiaolong Zhao, Qindong Mi, Wei Wang, Wenwei Qian, Jin Lin
Background: Robotic-assisted total knee arthroplasty (RA-TKA) has emerged as an advanced surgical technique. However, direct comparisons between Chinese and American robotic systems are limited.
Objective: Exploratory comparison of surgical accuracy and short-term clinical outcomes between Chinese HURWA and American MAKO robotic systems in total knee arthroplasty.
Methods: A prospective exploratory cohort study was conducted from September 2023 to January 2024. Eighty-five patients were assigned to undergo RA-TKA with either the HURWA system (n = 43) or the MAKO system (n = 42) based on the sequential clinical introduction of the systems. The primary outcomes were radiographic accuracy, including the restoration of the mechanical axis within ± 3°. Secondary outcomes encompassed surgical efficiency metrics and patient-reported clinical scores (WOMAC, HSS, VAS) assessed preoperatively and at one-year postoperatively.
Results: All included patients have completed surgery and follow-up.The two systems achieved a comparable and high proportion of mechanical axis restoration within ± 3° (HURWA: 86.05% vs. MAKO: 90.48%). The HURWA system demonstrated a significant advantage in osteotomy time (6.03 ± 2.35 vs. 8.06 ± 2.73 min, P < 0.001). Both groups exhibited substantial and comparable improvements in all clinical outcome scores at the one-year follow-up. The HURWA system, as an open-platform design, offered flexibility in prosthesis selection, while the MAKO system demonstrated a highly standardized workflow.
Conclusion: This exploratory comparison indicates that the HURWA system achieves favorable and comparable one-year clinical outcomes and radiographic alignment to the MAKO system in TKA, with distinct advantages in osteotomy efficiency and implant flexibility. These preliminary findings support the clinical potential of HURWA as a viable option, though definitive conclusions regarding its equivalence require validation through larger, long-term studies.
背景:机器人辅助全膝关节置换术(RA-TKA)已成为一项先进的外科技术。然而,中美机器人系统之间的直接比较是有限的。目的:探讨比较中国HURWA和美国MAKO机器人系统在全膝关节置换术中的手术精度和短期临床效果。方法:于2023年9月至2024年1月进行前瞻性探索性队列研究。85名患者被分配使用HURWA系统(n = 43)或MAKO系统(n = 42)进行RA-TKA,基于系统的顺序临床介绍。主要结果是影像学准确度,包括机械轴在±3°范围内的恢复。次要结果包括术前和术后1年评估的手术效率指标和患者报告的临床评分(WOMAC、HSS、VAS)。结果:所有患者均完成手术及随访。两种系统在±3°范围内实现了相当高的机械轴恢复比例(HURWA: 86.05% vs MAKO: 90.48%)。HURWA系统在截骨时间上具有显著优势(6.03±2.35 vs 8.06±2.73 min)。结论:该探索性比较表明,在TKA中,HURWA系统与MAKO系统相比具有良好的1年临床结果和相当的影像学一致性,在截骨效率和种植体灵活性方面具有明显优势。这些初步发现支持HURWA作为一种可行选择的临床潜力,尽管关于其等效性的明确结论需要通过更大规模的长期研究来验证。
{"title":"Comparative analysis of HURWA versus MAKO robotic-assisted TKA: a prospective cohort study of surgical accuracy and clinical outcomes.","authors":"Xiaolong Zhao, Qindong Mi, Wei Wang, Wenwei Qian, Jin Lin","doi":"10.1007/s11701-025-03020-x","DOIUrl":"10.1007/s11701-025-03020-x","url":null,"abstract":"<p><strong>Background: </strong>Robotic-assisted total knee arthroplasty (RA-TKA) has emerged as an advanced surgical technique. However, direct comparisons between Chinese and American robotic systems are limited.</p><p><strong>Objective: </strong>Exploratory comparison of surgical accuracy and short-term clinical outcomes between Chinese HURWA and American MAKO robotic systems in total knee arthroplasty.</p><p><strong>Methods: </strong>A prospective exploratory cohort study was conducted from September 2023 to January 2024. Eighty-five patients were assigned to undergo RA-TKA with either the HURWA system (n = 43) or the MAKO system (n = 42) based on the sequential clinical introduction of the systems. The primary outcomes were radiographic accuracy, including the restoration of the mechanical axis within ± 3°. Secondary outcomes encompassed surgical efficiency metrics and patient-reported clinical scores (WOMAC, HSS, VAS) assessed preoperatively and at one-year postoperatively.</p><p><strong>Results: </strong>All included patients have completed surgery and follow-up.The two systems achieved a comparable and high proportion of mechanical axis restoration within ± 3° (HURWA: 86.05% vs. MAKO: 90.48%). The HURWA system demonstrated a significant advantage in osteotomy time (6.03 ± 2.35 vs. 8.06 ± 2.73 min, P < 0.001). Both groups exhibited substantial and comparable improvements in all clinical outcome scores at the one-year follow-up. The HURWA system, as an open-platform design, offered flexibility in prosthesis selection, while the MAKO system demonstrated a highly standardized workflow.</p><p><strong>Conclusion: </strong>This exploratory comparison indicates that the HURWA system achieves favorable and comparable one-year clinical outcomes and radiographic alignment to the MAKO system in TKA, with distinct advantages in osteotomy efficiency and implant flexibility. These preliminary findings support the clinical potential of HURWA as a viable option, though definitive conclusions regarding its equivalence require validation through larger, long-term studies.</p>","PeriodicalId":47616,"journal":{"name":"Journal of Robotic Surgery","volume":"20 1","pages":"175"},"PeriodicalIF":3.0,"publicationDate":"2026-01-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12804221/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145967600","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-14DOI: 10.1007/s11701-026-03152-8
Siman Antar, Inara Merani, Mark G Hall, Sarah D Corn, Ali Ahmad
Robotic approach to hepatectomy has shown promise in recent times. The aim of our study was to identify the impact of various patient variables on outcomes from robotic major and minor hepatectomy. Data on 167 consecutive robotic hepatectomy procedures at our institution was retrospectively analyzed. Perioperative outcomes were analyzed for both minor and major hepatectomy. For major hepatectomy (n = 66), factors associated with increased operative time included cirrhosis (301 vs. 257 min) and obesity (310 vs. 261 min). Estimated blood loss (EBL) was worse in patients with underlying cirrhosis (242 vs. 161 mL), obesity (215 vs. 148mL) and tumor size ≥ 10 cm (232 vs. 136mL). Length of hospital stay (LOS) was also longer with age ≥ 70 years (5.9 vs. 4.5 days), cirrhosis (5.6 vs. 4.6 days) and malignant tumor pathology (5.1 vs. 3.8 days). Similarly, increased postoperative complications were seen with cirrhosis and tumor size ≥ 10 cm. For minor hepatectomy (n = 101), operative time was longer in patients with cirrhosis (139 vs. 105 min), obesity (141 vs. 115 min) and posterior-superior (PS) liver resection (168 vs. 104 min). Similarly, EBL was higher in cirrhotic patients (163 vs. 58mL) and those with PS resection (152 vs. 64mL). Longer LOS was observed in elderly patients (2.9 vs. 2.0 days), cirrhosis (2.9 vs. 2.1 days) and PS resection (2.8 vs. 2.1 days). Our study offers a comprehensive understanding of the impact of clinicopathologic factors on outcomes and can be utilized as a guide to appropriate patient selection, especially for surgeons starting a robotic hepatectomy practice.
近年来,机器人肝切除术已显示出前景。我们研究的目的是确定各种患者变量对机器人大、小肝切除术结果的影响。回顾性分析我院167例连续机器人肝切除术的数据。分析小肝切除术和大肝切除术的围手术期结果。对于大肝切除术(n = 66),与手术时间增加相关的因素包括肝硬化(301对257分钟)和肥胖(310对261分钟)。潜在肝硬化(242 vs 161 mL)、肥胖(215 vs 148mL)和肿瘤大小≥10 cm (232 vs 136mL)患者的估计失血量(EBL)更差。住院时间(LOS)也随着年龄≥70岁(5.9 vs. 4.5天)、肝硬化(5.6 vs. 4.6天)和恶性肿瘤病理(5.1 vs. 3.8天)而变长。同样,肝硬化和肿瘤大小≥10 cm的患者术后并发症增加。对于轻度肝切除术(n = 101),肝硬化(139比105分钟)、肥胖(141比115分钟)和后上(PS)肝切除术(168比104分钟)患者的手术时间更长。同样,肝硬化患者(163比58mL)和PS切除术患者(152比64mL)的EBL更高。老年患者(2.9天vs. 2.0天)、肝硬化患者(2.9天vs. 2.1天)和PS切除术患者(2.8天vs. 2.1天)的LOS较长。我们的研究提供了对临床病理因素对结果的影响的全面理解,可以作为适当患者选择的指导,特别是对于开始机器人肝切除术实践的外科医生。
{"title":"Impact of patient factors on outcomes in robotic major and minor hepatectomy: importance of patient selection.","authors":"Siman Antar, Inara Merani, Mark G Hall, Sarah D Corn, Ali Ahmad","doi":"10.1007/s11701-026-03152-8","DOIUrl":"https://doi.org/10.1007/s11701-026-03152-8","url":null,"abstract":"<p><p>Robotic approach to hepatectomy has shown promise in recent times. The aim of our study was to identify the impact of various patient variables on outcomes from robotic major and minor hepatectomy. Data on 167 consecutive robotic hepatectomy procedures at our institution was retrospectively analyzed. Perioperative outcomes were analyzed for both minor and major hepatectomy. For major hepatectomy (n = 66), factors associated with increased operative time included cirrhosis (301 vs. 257 min) and obesity (310 vs. 261 min). Estimated blood loss (EBL) was worse in patients with underlying cirrhosis (242 vs. 161 mL), obesity (215 vs. 148mL) and tumor size ≥ 10 cm (232 vs. 136mL). Length of hospital stay (LOS) was also longer with age ≥ 70 years (5.9 vs. 4.5 days), cirrhosis (5.6 vs. 4.6 days) and malignant tumor pathology (5.1 vs. 3.8 days). Similarly, increased postoperative complications were seen with cirrhosis and tumor size ≥ 10 cm. For minor hepatectomy (n = 101), operative time was longer in patients with cirrhosis (139 vs. 105 min), obesity (141 vs. 115 min) and posterior-superior (PS) liver resection (168 vs. 104 min). Similarly, EBL was higher in cirrhotic patients (163 vs. 58mL) and those with PS resection (152 vs. 64mL). Longer LOS was observed in elderly patients (2.9 vs. 2.0 days), cirrhosis (2.9 vs. 2.1 days) and PS resection (2.8 vs. 2.1 days). Our study offers a comprehensive understanding of the impact of clinicopathologic factors on outcomes and can be utilized as a guide to appropriate patient selection, especially for surgeons starting a robotic hepatectomy practice.</p>","PeriodicalId":47616,"journal":{"name":"Journal of Robotic Surgery","volume":"20 1","pages":"174"},"PeriodicalIF":3.0,"publicationDate":"2026-01-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145967504","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
To compare early and late complications rates after robot-assisted radical cystectomy for muscle invasive bladder tumors and certain high-risk non-muscle-invasive tumors according to the type of reconstruction. We conducted a single-center retrospective study including 109 patients who underwent robot-assisted radical cystectomy between 2008 and 2022. Patients were divided into two groups based on urinary diversion: extracorporeal Bricker ileal conduit (n = 74) or orthotopic neobladder (n = 35). Complications were graded by the Clavien-Dindo classification. Multivariate analysis identified independent risk factors for morbidity and mortality. Operative time was significantly longer for neobladder reconstruction (320 vs. 291 min, p = 0.047), as was hospital stay (14 vs. 10 days, p < 0.001). Early complications (< 30 days) occurred in 59.6% of patients, with a higher rate of minor complications in the neobladder group (57.1% vs. 28.4%, p = 0.006). There was no significant difference in major complications (Clavien III-V) or late complications (> 30 days), which affected 47.7% of patients. Operative time was an independent risk factor for major complications (OR = 1.15 per additional 15 min). Neobladder reconstruction was associated with increased early morbidity, mainly minor, without impact on late morbidity or mortality. Urinary diversion choice should be guided by patient profile and expected functional benefits.
比较机器人辅助根治性膀胱肌肉浸润性肿瘤与某些高危非肌肉浸润性肿瘤根据重建类型的早期和晚期并发症发生率。我们进行了一项单中心回顾性研究,包括109名在2008年至2022年间接受机器人辅助根治性膀胱切除术的患者。患者根据尿分流分为两组:体外砖头回肠导管(n = 74)和原位新膀胱(n = 35)。并发症采用Clavien-Dindo分级。多变量分析确定了发病率和死亡率的独立危险因素。新膀胱重建术的手术时间明显更长(320 vs 291分钟,p = 0.047),住院时间明显更长(14 vs 10天,p = 30天),影响了47.7%的患者。手术时间是主要并发症的独立危险因素(OR = 1.15 /每增加15分钟)。新膀胱重建与早期发病率增加有关,主要是轻微的,对晚期发病率或死亡率没有影响。尿转移的选择应根据患者的情况和预期的功能益处来指导。
{"title":"Morbi-mortality of robot-assisted radical cystectomy for bladder carcinoma by urinary diversion type.","authors":"Corentin Deniaud, Benoit Mesnard, Soline Bobet, Marie-Aimée Perrouin-Verbe, Julien Branchereau, Stéphane De Vergie, Jérôme Rigaud","doi":"10.1007/s11701-025-03059-w","DOIUrl":"https://doi.org/10.1007/s11701-025-03059-w","url":null,"abstract":"<p><p>To compare early and late complications rates after robot-assisted radical cystectomy for muscle invasive bladder tumors and certain high-risk non-muscle-invasive tumors according to the type of reconstruction. We conducted a single-center retrospective study including 109 patients who underwent robot-assisted radical cystectomy between 2008 and 2022. Patients were divided into two groups based on urinary diversion: extracorporeal Bricker ileal conduit (n = 74) or orthotopic neobladder (n = 35). Complications were graded by the Clavien-Dindo classification. Multivariate analysis identified independent risk factors for morbidity and mortality. Operative time was significantly longer for neobladder reconstruction (320 vs. 291 min, p = 0.047), as was hospital stay (14 vs. 10 days, p < 0.001). Early complications (< 30 days) occurred in 59.6% of patients, with a higher rate of minor complications in the neobladder group (57.1% vs. 28.4%, p = 0.006). There was no significant difference in major complications (Clavien III-V) or late complications (> 30 days), which affected 47.7% of patients. Operative time was an independent risk factor for major complications (OR = 1.15 per additional 15 min). Neobladder reconstruction was associated with increased early morbidity, mainly minor, without impact on late morbidity or mortality. Urinary diversion choice should be guided by patient profile and expected functional benefits.</p>","PeriodicalId":47616,"journal":{"name":"Journal of Robotic Surgery","volume":"20 1","pages":"173"},"PeriodicalIF":3.0,"publicationDate":"2026-01-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145965943","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-13DOI: 10.1007/s11701-025-03098-3
Hao Ge, Xiaoru Fang, Biqing Dou, Kai Wang
To evaluate the effectiveness of a phased active warming protocol in preventing intraoperative hypothermia during Da Vinci robot-assisted radical resection for rectal cancer. A single-center retrospective cohort analysis examined patients undergoing Da Vinci robot-assisted rectal cancer resection from January 1, 2022, through December 31, 2024. Using 1:1 propensity score matching, patients receiving phased active warming protocol were matched with those under routine thermal care. Variables for matching encompassed age, sex, body mass index, American Society of Anesthesiologists classification, surgical duration, and anesthesia time. Primary outcome measured was intraoperative hypothermia incidence (core temperature below 36 °C). Secondary outcomes covered mean core temperature, postoperative shivering evaluated through Bedside Shivering Assessment Scale, surgical site infection rates, blood transfusion needs, hospital stay duration, and perioperative costs. Following propensity score matching, each group contained 144 patients (total n = 288). Hypothermia occurrence dropped markedly in the intervention cohort (26 cases [18.1%] versus 70 cases [48.6%], p < 0.001). End-of-surgery core temperature showed higher values in the intervention cohort (36.4 ± 0.5 °C compared to 35.8 ± 0.6 °C, p < 0.001). Shivering after surgery (BSAS score of 1 or greater) demonstrated reduced frequency in the intervention cohort (18 patients [12.5%] versus 50 patients [34.7%], p < 0.001). Wound infection rates decreased in the intervention cohort (6 cases [4.2%] versus 17 cases [11.8%], p = 0.022). Hospital stays shortened for the intervention cohort (8.2 ± 2.1 days compared to 10.5 ± 3.4 days, p < 0.001). The phased active warming approach substantially decreased hypothermia occurrence and enhanced perioperative outcomes in Da Vinci robot-assisted rectal cancer resection patients, demonstrating clinical value warranting widespread adoption.
{"title":"Phased active warming protocol for prevention of intraoperative hypothermia in Da Vinci robot-assisted radical resection of rectal cancer.","authors":"Hao Ge, Xiaoru Fang, Biqing Dou, Kai Wang","doi":"10.1007/s11701-025-03098-3","DOIUrl":"https://doi.org/10.1007/s11701-025-03098-3","url":null,"abstract":"<p><p>To evaluate the effectiveness of a phased active warming protocol in preventing intraoperative hypothermia during Da Vinci robot-assisted radical resection for rectal cancer. A single-center retrospective cohort analysis examined patients undergoing Da Vinci robot-assisted rectal cancer resection from January 1, 2022, through December 31, 2024. Using 1:1 propensity score matching, patients receiving phased active warming protocol were matched with those under routine thermal care. Variables for matching encompassed age, sex, body mass index, American Society of Anesthesiologists classification, surgical duration, and anesthesia time. Primary outcome measured was intraoperative hypothermia incidence (core temperature below 36 °C). Secondary outcomes covered mean core temperature, postoperative shivering evaluated through Bedside Shivering Assessment Scale, surgical site infection rates, blood transfusion needs, hospital stay duration, and perioperative costs. Following propensity score matching, each group contained 144 patients (total n = 288). Hypothermia occurrence dropped markedly in the intervention cohort (26 cases [18.1%] versus 70 cases [48.6%], p < 0.001). End-of-surgery core temperature showed higher values in the intervention cohort (36.4 ± 0.5 °C compared to 35.8 ± 0.6 °C, p < 0.001). Shivering after surgery (BSAS score of 1 or greater) demonstrated reduced frequency in the intervention cohort (18 patients [12.5%] versus 50 patients [34.7%], p < 0.001). Wound infection rates decreased in the intervention cohort (6 cases [4.2%] versus 17 cases [11.8%], p = 0.022). Hospital stays shortened for the intervention cohort (8.2 ± 2.1 days compared to 10.5 ± 3.4 days, p < 0.001). The phased active warming approach substantially decreased hypothermia occurrence and enhanced perioperative outcomes in Da Vinci robot-assisted rectal cancer resection patients, demonstrating clinical value warranting widespread adoption.</p>","PeriodicalId":47616,"journal":{"name":"Journal of Robotic Surgery","volume":"20 1","pages":"172"},"PeriodicalIF":3.0,"publicationDate":"2026-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145960585","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}